JPRN-jRCT2080222355Other3 期
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Rheumatoid Arthritis
适应症
试验速览
- 阶段
- 3 期
- 状态
- Other
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Male or female patients at least 18 years of age who have been diagnosed with RA and have completed the final study visit in a previous baricitinib RA study
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase 3 Study in Rheumatoid ArthritisRheumatoid arthritisEUCTR2012-003686-17-GREli Lilly and Company3,350
进行中（未招募）
1 期
A Phase 3 Study in Rheumatoid ArthritisRheumatoid arthritisEUCTR2012-003686-17-PTEli Lilly and Company3,350
进行中（未招募）
1 期
A Phase 3 Study in Rheumatoid ArthritisMedDRA version: 19.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2012-003686-17-HUEli Lilly and Company3,350
进行中（未招募）
1 期
A Phase 3 Study in Rheumatoid ArthritisMedDRA version: 21.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2012-003686-17-LTEli Lilly and Company2,876
进行中（未招募）
1 期
A Phase 3 Study in Rheumatoid ArthritisMedDRA version: 20.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2012-003686-17-ATEli Lilly and Company3,350